These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22417066)

  • 1. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis.
    Fang Y; DeMarco VG; Nicholl MB
    Cancer Sci; 2012 Jun; 103(6):1090-8. PubMed ID: 22417066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role for resveratrol as a radiation sensitizer for melanoma treatment.
    Fang Y; Bradley MJ; Cook KM; Herrick EJ; Nicholl MB
    J Surg Res; 2013 Aug; 183(2):645-53. PubMed ID: 23522452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of resveratrol and radiotherapy in control of cancers.
    Kma L
    Asian Pac J Cancer Prev; 2013; 14(11):6197-208. PubMed ID: 24377505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible role for perforin and granzyme B in resveratrol-enhanced radiosensitivity of prostate cancer.
    Fang Y; Herrick EJ; Nicholl MB
    J Androl; 2012; 33(4):752-60. PubMed ID: 22096086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.
    Luo H; Wang L; Schulte BA; Yang A; Tang S; Wang GY
    Int J Oncol; 2013 Dec; 43(6):1999-2006. PubMed ID: 24141489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
    Ghashghaei M; Niazi TM; Heravi M; Bekerat H; Trifiro M; Paliouras M; Muanza T
    Prostate; 2018 Jan; 78(1):64-75. PubMed ID: 29134684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
    Kai L; Samuel SK; Levenson AS
    Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.
    Rashid A; Liu C; Sanli T; Tsiani E; Singh G; Bristow RG; Dayes I; Lukka H; Wright J; Tsakiridis T
    Radiat Oncol; 2011 Oct; 6():144. PubMed ID: 22029423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
    Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
    Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated Physiological Resveratrol Metabolites Induce Senescence in Breast Cancer Cells: Role of p53/p21 and p16/Rb Pathways, and ABC Transporters.
    Giménez-Bastida JA; Ávila-Gálvez MÁ; Espín JC; González-Sarrías A
    Mol Nutr Food Res; 2019 Nov; 63(22):e1900629. PubMed ID: 31441212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.
    Colin DJ; Limagne E; Ragot K; Lizard G; Ghiringhelli F; Solary É; Chauffert B; Latruffe N; Delmas D
    Cell Death Dis; 2014 Nov; 5(11):e1533. PubMed ID: 25412311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
    Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
    Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
    Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
    Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effect of resveratrol in human prostate carcinoma cells.
    Kim YA; Rhee SH; Park KY; Choi YH
    J Med Food; 2003; 6(4):273-80. PubMed ID: 14977434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
    Conti S; Vexler A; Hagoel L; Kalich-Philosoph L; Corn BW; Honig N; Shtraus N; Meir Y; Ron I; Eliaz I; Lev-Ari S
    Integr Cancer Ther; 2018 Dec; 17(4):1225-1234. PubMed ID: 30043669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.
    Phelps D; Bondra K; Seum S; Chronowski C; Leasure J; Kurmasheva RT; Middleton S; Wang D; Mo X; Houghton PJ
    Pediatr Blood Cancer; 2015 Aug; 62(8):1345-52. PubMed ID: 25832557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells.
    Liao PC; Ng LT; Lin LT; Richardson CD; Wang GH; Lin CC
    J Med Food; 2010 Dec; 13(6):1415-23. PubMed ID: 20946021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.
    Huamani J; Willey C; Thotala D; Niermann KJ; Reyzer M; Leavitt L; Jones C; Fleishcher A; Caprioli R; Hallahan DE; Kim DW
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):237-46. PubMed ID: 18337021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1.
    Tan Y; Wei X; Zhang W; Wang X; Wang K; Du B; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1833-1841. PubMed ID: 28184930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.